"Are we close to curing diseases like ALS and Alzheimer's?" In recent years, several academic and industry endeavors have given reason to be hopeful. Toby Ferguson, MD, PhD, is the Chief Medical Officer at Voyager Therapeutics, which develops genetic medicines and delivery tools to cross the blood-brain barrier (BBB). In this episode, Ferguson explains the current state of therapeutics for neurological and neurodegenerative diseases, challenges in delivering genetic medicines and other therapeutics to the nervous system, and Voyager's approach to overcoming the BBB.

Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.

Produced by Bill Levine

Hosted by Jonathan D. Grinstein

Music provided by Artem Hramushkin

Audio mixed and mastered by Jason Mack

Hosted on Acast. See acast.com/privacy for more information.